Elevation Oncology Gets FDA Fast-Track Designation for EO-3021 | Morningstar

[Global News Select](/news/dow-jones) Elevation Oncology Gets FDA Fast-Track Designation for EO-3021 By Colin Kellaher Elevation Oncology has won Food and Drug Administration fast-track designation for EO-3021, its lead drug candidate, in c
Read more...